Modulatory effects of hydrochlorothiazide and triamterene on resistant hypertension patients
نویسندگان
چکیده
The present study explored the modulatory potential of hydrochlorothiazide and triamterene on resistant hypertension patients. The mechanistic information for resistant hypertension was explored by studying the pressure-natriuresis curves between the salt sensitive population and non-salt sensitive population. A cohort of 23 patients with non-hypertension (NH) (13 males and 10 females; aged from 23 to 62 years), 26 patients with controlled hypertension (CH) (14 males and 12 females; aged from 19 to 72 years) and 23 patients with resistant hypertension (RH) (13 males and 10 females; aged from 19 to 76 years) were selected. The patients were divided into two main groups on the basis of salt sensitivity viz. salt sensitive (SS) and non-SS (NSS) groups. These two groups were further classified into four subgroups based on the diuretic drug used. Hydrochlorothiazide-treated subgroups were named as salt sensitive hydrochlorothiazide (SSHy) and non-SSHy (NSSHy) groups. Similarly, triamterene-treated subgroups were named as salt sensitive triamterene (SSTr) and non-SSTr (NSSTr) groups. Treatment continued for 2 weeks and the pressure-natriuresis curves were recorded. Additionally, the plasma aldosterone and renin activity was monitored by radioimmunoassay. The pressure-natriuresis curves of the SS group were shifted towards the right relative to NSS group. On the other hand, hydrochlorothiazide and triamterene treatments reversed the changes of pressure-natriuresis curves. Moreover, significant differences were observed among various important indices including plasma aldosterone, renin activity, office blood pressure as evaluated by the chronic salt load test and diuretic intervention tests. The study concludes that hydrochlorothiazide and triamterene hold good potential as an efficient modulator of resistive hypertension.
منابع مشابه
Lithium toxicity induced by triamterene-hydrochlorothiazide.
Two patients on long-term lithium therapy for manic-depressive psychosis developed serious toxicity within days of being prescribed a combination of triamterene (50 mg) and hydrochlorothiazide (25 mg) for mild symptomless hypertension. Reduced clearance of lithium has been reported to follow its concurrent administration with diuretics that deplete both sodium and potassium. A combination of tr...
متن کاملPotassium-sparing effects of triamterene in the treatment of hypertension.
T RIAMTERENE (2,4,7-triamino-6-phenylpteridine) is the first of a relatively new class of diuretics to become available for clinical investigation and therapeutic use. It has been demonstrated to be an antagonist of mineralocorticoids in addition to having a direct diuretic effect in adrenalectomized animals and humans.1-7 Administration of triamterene increases the urinary excretion of sodium,...
متن کاملDiuretics--a risk in the long-term treatment of hypertensive patients?
The trial of the European Working Party on High blood pressure in the Elderly (EWPHE) revealed an overall decrease in cardiovascular mortality and morbidity in the actively treated patients. They received as first-line drugs a combination of hydrochlorothiazide and triamterene; methyldopa was added as necessary. The present post hoc analysis examined the effect of the diuretic treatment on card...
متن کاملDiffering effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
This study tests the hypothesis that spironolactone influences plasminogen activator inhibitor-1 (PAI-1) concentrations through mineralocorticoid receptor antagonism rather than through changes in potassium. Effects of spironolactone (50 mg per day) and triamterene (50 mg per day) on fibrinolytic balance were compared in 18 normotensive and 20 hypertensive subjects pretreated with hydrochloroth...
متن کاملAntihypertensive drugs and lip cancer in non-Hispanic whites.
BACKGROUND In screening pharmaceuticals for possible carcinogenic effects we noted an association between lip cancer risk and the photosensitizing antihypertensive drugs hydrochlorothiazide and nifedipine. In this study, we further characterized the risk of lip cancer associated with these and other commonly used antihypertensive drugs. METHODS In a comprehensive medical care program, we eval...
متن کامل